Abstract
Interim Report on the Safety and Efficacy of Longer-Term Treatment With Nusinersen in Infantile-Onset Spinal Muscular Atrophy (SMA): Updated Results From the SHINE Study (S25.004)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have